Otros idiomas SK Discovery Co., Ltd. Korea S.E.

Acciones

A006125

KR7006121008

Precio de cierre Korea S.E. Otros sitios de cotización 00:00:00 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
32.100 ^KRW	+0,47 %		+3,55 %	+4,90 %

11/03	SK Discovery Co. Resultados del ejercicio cerrado el 31 de diciembre de 2023	CI
05/03	SK Discovery Co. (KOSE:A006120) anuncia una recompra de acciones por valor de 20.000 millones de KRW.	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

SK Discovery : chemicals, Dongsung Chemical, and Black Yak Collaborate on Commercializing Sustainable Footwear	22/04
SK Discovery : D&D signs MOU with the largest global co-living provider Habyt to strengthen residential business	17/04
SK Discovery : chemicals Achieves Upgraded “AA” MSCI ESG Rating	08/04
SK Discovery Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	11/03
SK Discovery Co., Ltd. announces an Equity Buyback for KRW 20,000 million worth of its shares.	05/03
SK Discovery Co., Ltd. authorizes a Buyback Plan.	05/03
Tranche Update on SK Discovery Co., Ltd.'s Equity Buyback Plan announced on July 21, 2023.	22/01
Tranche Update on SK Discovery Co., Ltd.'s Equity Buyback Plan announced on July 21, 2023.	22/01
SK Discovery Co., Ltd.'s Equity Buyback announced on July 21, 2023, has expired with 252,000 shares, representing 1.28% for KRW 9,963.12 million.	22/01
SK Discovery : Administration of Novavax’s Updated COVID-19 Vaccine Will Begin in Korea on December 18	12/12
SK Discovery : bioscience and Sanofi Initiate Submission of Phase III Study Investigational New Drug Amendment to the U.S. FDA of 21-Valent Pneumococcal Conjugate Vaccine Candidate	11/12
SK Group Boss' Cousin to Head SK SUPEX Council	06/12
SK Discovery : bioscience Expands L HOUSE for Preparing Commercialization of Next-Generation Pneumococcal Vaccine	28/11
SK Discovery : bioscience and Hilleman Laboratories Announce Joint Development of Second -Generation Zaire Ebola Virus Vaccine	22/11
SK Discovery Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Tranche Update on SK Discovery Co., Ltd.'s Equity Buyback Plan announced on July 21, 2023.	25/10/23
SK Discovery : chemicals, Storing Music in Circular Recycled Plastics	19/10/23
SK Discovery : “Packaging Sustainability in the Global Cosmetics Market” SK chemicals Partners with The Estee Lauder Companies	17/10/23
SK Discovery : “Dominating the Waste Plastic Value Chain” SK chemicals Forms Partnership with Global Waste Resource Collection Innovation Company	04/10/23
SK Discovery : chemicals Obtains APR Critical Guidance Recognition (ACGR) for 5 Types of Recyclable Materials	30/08/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas SK Discovery Co., Ltd. Korea S.E.

Acciones

A006125

KR7006121008

Otros idiomas

Filtros